Trial ID or NCT#

NCT02603562

Status

recruiting iconRECRUITING

Purpose

To assess the safety, tolerability, immunogenicity, and efficacy of the study medication, ATYR1940 in early onset FSHD.

Investigator(s)

John W. Day, MD, PhD

Contact us to find out if this trial is right for you.

CONTACT

Jennifer Perez